SC says no person should be denied COVID treatment due to cost

▴ SC says no person should be denied COVID treatment due to cost
Supreme Court says private hospitals on public land must provide free treatment to poor patients

No one should be turned away from a hospital due to higher cost of treatment, the Supreme Court said on Tuesday while asking the government to consider framing guidelines on the issue of cost of treatment for COVID-19 infection.

Though the apex court opined that cost of the treatment should not be higher at the present time, it also said that court is not equipped to either regulate cost of treatment or say what should be the best model of treatment for patients infected with coronavirus.

A bench comprising Chief Justice SA Bobde and Justices RS Reddy and AS Bopanna, was hearing through video-conferencing a plea filed by advocate Sachin Jain who has sought a direction for regulating the cost of treatment of COVID-19 at private hospitals across the country.

Solicitor General Tushar Mehta, appearing for the Centre, told the bench that government is looking into all the issues related to coronavirus and concerns raised by the petitioner would be taken care of.

During the hearing, the bench referred to the affidavit filed earlier in the matter by the Centre which had said that there is no provision under the Clinical Establishments (Registration and Regulation) Act, 2010 "whereby it is mandated that the private hospitals running on the public land shall treat COVID-19 patients on free basis".

"It is again reiterated that such policies may only be defined and implemented by the respective state governments," the Centre's affidavit had said.

The counsel appearing for federation of private hospitals said that states have their own models and there cannot be a uniform pricing for all the states.

He said as far as charitable hospitals are concerned, they are already providing free treatment to COVID-19 patients.

He said each state is grappling with the problem of coronavirus and it is not that private hospitals are making money during the time of pandemic.

Jain claimed in the court that some private hospitals are charging exorbitant rates for COVID-19 treatment at this time of this pandemic.

The apex court said that concerned authority of Union health ministry should consider framing guideline on this aspect.

In June, the apex court had asked private hospitals whether they were ready to provide treatment to Covid-19 infected patients at the charges prescribed under the government's Ayushman Bharat Scheme.

The 'Ayushman Bharat Pradhan Mantri Jan Arogya Yojana' is aimed at providing health cover to poor and vulnerable persons in the country.

The court had earlier said it is asking only those private hospitals, which have been given land at concessional rates by the government, to treat certain number of coronavirus infected patients for free.

Mehta had earlier told the court that government is doing its best for the lowest strata of society, and people who cannot afford treatment are covered under the Ayushman Bharat scheme.

In its affidavit filed in the court, the Centre had said, "It is therefore submitted that the Central Government, within its statutory powers or powers of delegated legislation, cannot make this particular bifurcation for the lack of a requisite statutory framework for the said classification".

It had said that entire health infrastructure has been brought to most appropriate use for treatment of Covid-19 in the country and the Centre has taken several measures to strengthen public health facilities where medical care is provided free of cost to all patients.

"The care cost in the private sector is not regulated by the Central Government," the affidavit had said.

PTI

Tags : #SupremeCourt #PrivateHospitals #ChariatableHospitals #AyushmanBharat #SABobde #RSReddy #ASBopanna #CovidNewsUpdate

About the Author


Team Medicircle

Related Stories

12 Mar

“Every Human Being Deserves a Better Health Care at a Better Price” says Amit Bansal, CEO, MediGence

“We are always focused around creating the best tools and technology to improve the patient experience by giving a platform that allows patient to connect with the doctors of other countries,” says Amit Bansal, CEO, MediGence.

View
13 Nov

Medigen and BlueWillow Biologics partner to develop Intranasal Vaccine for SARS-CoV-2

Intranasal vaccine would be first of it's kind if approved

View
13 Nov

Prestige Biopharma and Teva Israel signs license and supply agreement for Prestige's Trastuzumab Biosimilar in Israel

Tuznue is a mAb biosimilar to Roche’s Herceptin (trastuzumab)

View
13 Nov

ViiV Healthcare announces CHMP positive opinion for the first-ever dispersible-tablet formulation of dolutegravir, Tivicay, a treatment for children living with HIV in Europe

Dolutegravir is the first integrase inhibitor available as a dispersible tablet for children

View
13 Nov

NATCO receives Pomalidomide approval for US market

Celgene, sells Pomalidomide Capsules under the Brand name POMALYST, for the treatment of patients suffering from multiple myeloma cancer

View
13 Nov

Vapogenix Awarded $1.5M Phase II SBIR grant to develop topical therapy for Painful Inflammatory Conditions

This work will allow Vapogenix to meet with the U.S. Food and Drug Administration (FDA) to finalize an Investigational New Drug (IND)-application

View
10 Nov

Altimmune adds Lonza as a Manufacturing Partner for supply of AdCOVID,

AdCovid is its single-dose Intranasal vaccine candidate for COVID-19

View
15 Oct

Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody levels in preclinical studies

Sanofi and Translate Bio today announced the preclinical results of an mRNA-based vaccine candidate against SARS-CoV-2

View

-Advertisements-




Trending Now

The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025